Walleye Trading
CORT icon

Walleye Trading’s Corcept Therapeutics CORT Stock Holding History

Walleye Trading’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,848
Closed -$37.5K – 4908
2022
Q4 		$37.5K Buy
+1,848
New +$46.3K ﹤0.01% 4257
2021
Q3 		– Sell
-2,523
Closed -$52.8K – 5271
2021
Q2 		$56K Buy
+2,523
New +$56.1K ﹤0.01% 4587
2020
Q4 		– Sell
-16,447
Closed -$347K – 4642
2020
Q3 		$286K Buy
+16,447
New +$262K ﹤0.01% 2699
2020
Q1 		– Sell
-10,124
Closed -$123K – 4047
2019
Q4 		$123K Buy
10,124
+6,531
+182% +$90.9K ﹤0.01% 3456
2019
Q3 		$51K Buy
+3,593
New +$44.1K ﹤0.01% 3564
2017
Q4 		– Sell
-31,485
Closed -$608K – 4384
2017
Q3 		$608K Buy
+31,485
New +$469K ﹤0.01% 2291
2017
Q2 		– Sell
-84,700
Closed -$921K – 4550
2017
Q1 		$928K Buy
84,700
+38,100
+82% +$335K 0.01% 1713
2016
Q4 		$338K Buy
46,600
+26,600
+133% +$208K ﹤0.01% 2398
2016
Q3 		$130K Buy
20,000
+19,600
+4,900% +$114K ﹤0.01% 3092
2016
Q2 		$2K Buy
+400
New +$2.08K ﹤0.01% 5105
2016
Q1 		– Sell
-500
Closed -$2K – 5384
2015
Q4 		$2K Sell
500
-1,500
-75% -$6.77K ﹤0.01% 5079
2015
Q3 		$8K Buy
+2,000
New +$10.2K ﹤0.01% 4455

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Trading's CORT Position: Q1 2023 in Review

Walleye Trading sold out of Corcept Therapeutics (CORT) in Q1 2023, closing a stake of 1,848 shares — an estimated $37.5K sold.

Walleye Trading first reported a position in CORT in Q3 2015 and held it in 12 quarters. The position peaked at $928K in Q1 2017. 232 funds tracked by Wall St. Rank hold CORT as of Q1 2023.

  • Walleye Trading reported no remaining Corcept Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 1,848 Corcept Therapeutics shares in Q1 2023, an estimated $37.5K.
  • Walleye Trading first reported a position in Corcept Therapeutics in Q3 2015 and held it in 12 quarters.
  • Walleye Trading's Corcept Therapeutics position peaked at $928K in Q1 2017.
  • 232 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.